4.8 Article

IFN-γ abrogates endotoxin tolerance by facilitating Toll-like receptor-induced chromatin remodeling

出版社

NATL ACAD SCIENCES
DOI: 10.1073/pnas.1007816107

关键词

inflammation; innate immunity; macrophage

资金

  1. Cancer Research Institute
  2. National Institutes of Health

向作者/读者索取更多资源

An important mechanism by which IFN-gamma Primes macrophages for enhanced innate immune responses is abrogation of feedback inhibitory pathways. Accordingly, IFN-gamma abrogates endotoxin tolerance, a major negative feedback loop that silences expression of inflammatory cytokine genes in macrophages previously exposed to endotoxin/Toll-like receptor (TLR) ligands. Mechanisms by which IFN-gamma inhibits endotoxin tolerance have not been elucidated. Here, we show that pretreatment with IFN-gamma prevented tolerization of primary human monocytes and restored TLR4-mediated induction of various proinflammatory cytokines, including IL-6 and TNF alpha. Surprisingly, IFN-gamma did not alter proximal TLR4 signaling defects in tolerized monocytes. Instead, IFN-gamma blocked tolerance-associated down-regulation of IL6 and TNF transcription, RNA polymerase II recruitment, and NF-kappa B and CCAAT/enhancer-binding protein beta transcription factor binding to the IL6 and TNF promoters in tolerized monocytes. The mechanism by which IFN-gamma restored IL6 expression was by facilitating TLR4-induced recruitment of chromatin remodeling machinery to the IL6 promoter and promoting IL6 locus accessibility in tolerized monocytes. Our results suggest that IFN-gamma overcomes endotoxin tolerance by facilitating TLR-induced chromatin remodeling to allow expression of proinflammatory genes. These results identify a mechanism by which IFN-gamma promotes activation of macrophages and highlight the importance of chromatin remodeling and transcriptional control in the regulation of inflammatory cytokine production in tolerant and activated macrophages.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据